Published April 4, 2014
| Published
Patent
Open
Imidazo bibyclic imminium compounds as antitumor agents
Abstract
The invention relates to imidazobicycles having a quaternary nitrogen that are inhibitors of the Hedgehog pathway and therefore useful as antitumor agents and as probes of the function of Hedgehog-dependent systems.
Additional Information
Appl. No.: 14/409,683 Filed: June 19, 2013 PCT Filed: June 19, 2013 PCT No.: PCT/US2013/046560 371(c)(1),(2),(4) Date: December 19, 2014 PCT Pub. No.: WO2013/192301 PCT Pub. Date: December 27, 2013. Government Interests: This invention was made with Government support under contract CA136574 awarded by the National Institutes of Health. The Government has certain rights in this invention. Parent Case Text: This application is a national phase filing under 35 U.S.C. .sctn.371 of PCT International Application PCT/US2013/046560, filed Jun. 19, 2013, and published under PCT Article 21(2) as WO 2013/192301 on Dec. 27, 2013. PCT/US2013/046560 claims priority from U.S. provisional application 61/662,977, filed Jun. 22, 2012. The contents of each of the prior applications are incorporated herein by reference in their entirety.Attached Files
Published - EP2864332B1.pdf
Published - US9611276B2.pdf
Files
US9611276B2.pdf
Files
(2.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:5f4ad4d2cce837755d61b1915cb56640
|
1.2 MB | Preview Download |
|
md5:d31582652b096df4bf7c6b77f4b7f0c8
|
1.1 MB | Preview Download |
Additional details
- Eprint ID
- 81083
- Resolver ID
- CaltechAUTHORS:20170901-135026964
- CA136574
- NIH
- Created
-
2017-09-21Created from EPrint's datestamp field
- Updated
-
2022-04-25Created from EPrint's last_modified field